Source: Virtual Congress 2021 – COVID – 19: treatments and predictive factors



Rating:

Share or cite this content

Citations should be made in the following way:
A. Vianello (Padova (PD), Italy), F. Braccioni (Padova (PD), Italy), G. Guarnieri (Padova (PD), Italy), B. Molena (Padova (PD), Italy), A. Achille (Padova (PD), Italy), S. Lococo (Padova (PD), Italy), L. Salviati (Padova (PD), Italy), E. Crisafulli (Verona (VR), Italy), L. Bertagna De Marchi (Padova (PD), Italy), M. Caminati (Verona (VR), Italy), G. Senna (Verona (VR), Italy). Alpha 1-Antitrypsin deficiency (AATD) in patients with ARDS consequent to SARS-CoV-2 infection.. 812

Member's Comments

No comment yet.

Related content which might interest you: Reduction in incidence of exacerbations in patients with alpha 1 antitrypsin deficiency (A1ATD) treated with concentrates of alpha 1 antitrypsin (A1AT): REXA study Source: Annual Congress 2011 - Biomarkers and exacerbations of asthma and COPD Year: 2011 Patterns of exacerbations in alpha 1 antitrypsin deficiency (AATD) Source: International Congress 2015 – Connective tissue disorders Year: 2015 Alpha 1 antitrypsin (A1AT) deficiency among patients with cystic fibrosis Source: Eur Respir J 2003; 22: Suppl. 45, 501s Year: 2003 Prevalence of alpha-1-antitrypsin deficiency (A1AD) in patients with COPD. Source: Virtual Congress 2021 – COPD burden, epidemiology and management Year: 2021 Alpha 1 antitrypsin (A1AT) deficiency in children with asthma in Brazil Source: Eur Respir J 2003; 22: Suppl. 45, 499s Year: 2003 Mortality in individuals with severe alpha-1-antitrypsin deficiency (PiZZ) Source: Eur Respir J 2006; 28: Suppl. 50, 144s Year: 2006 Clinical, functional, radiologic and quality of life characteristics in PI*SZ Alpha 1-Antitrypsin Deficiency (AATD) compared to PI*ZZ, PI*MZ and COPD without AATD: a retrospective cohort study. Source: Virtual Congress 2021 – Biomarkers to phenotype COPD: prediction of exacerbations Year: 2021 Prevalence of alpha-1 antitrypsin deficiency (AATD) and frequencies of alleles PI*S and PI*Z in patients with COPD in Brazil Source: Annual Congress 2013 –Assessing the prevalence of COPD in the general population Year: 2013 Predicting clinical course of alpha 1 anti-trypsin deficiency (AATD) using GOLD 2011 classification Source: Annual Congress 2013 –Predictors and triggers of asthma and COPD exacerbations Year: 2013 COVID-19 infection in Severe Alpha 1-antitrypsin deficiency: looking for a rationale Source: Virtual Congress 2021 – Burden and epidemiology of COVID-19 Year: 2021 Severity of lung disease in siblings with α-1-antitrypsin deficiency (AATD) Source: Annual Congress 2008 - COPD Year: 2008 Immune activation in α1 antitrypsin deficiency (AATD) emphysema: Beyond the protease/antiprotease hypothesis Source: Annual Congress 2012 - Mechanistic studies in airway cell biology Year: 2012 Exercise intolerance and lung emphysema in alpha-1 antitrypsin deficiency (AATD) Source: Annual Congress 2010 - Exercise in COPD Year: 2010 Association between alpha1 antitrypsin (AAT) circulating polymers (CP) and lung and liver disease in patients with AAT deficiency (AATD). Source: Virtual Congress 2021 – Molecular pathology and cell biology of pulmonary diseases Year: 2021 The effect of posture on ventilation using SLP in healthy subject and patients with Alpha 1 anti-trypsin deficiency (A1AT) Source: International Congress 2014 – Respiratory function: quality and new technologies Year: 2014 Laboratory testing of individuals with severe α1-antitrypsin deficiency in three European centres Source: Eur Respir J 2010; 35: 960-968 Year: 2010 Alpha-1 antitrypsin deficiency in patients with COPD/emphysema, bronchiectasis and asthma Source: Virtual Congress 2020 – New biomarkers for management of obstructive diseases Year: 2020 Functional alterations of small airways in patients with alpha-1 antitrypsin deficiency (AATD) in a longitudinal study Source: Eur Respir J 2005; 26: Suppl. 49, 361s Year: 2005